GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factor IX), a plasma‑derived concentrate for hemophilia B and other factor deficiencies. Request a quote.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX, the active ingredient in Octaplex, is a plasma‑derived coagulation factor presented as a sterile injectable for intravenous use. It replaces deficient clotting factors in patients with inherited or acquired bleeding disorders.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is used to manage bleeding disorders that involve deficiencies in the coagulation cascade. - Hemophilia B (Factor IX deficiency): provides factor IX replacement to control and prevent bleeding episodes. - Congenital Factor VII deficiency: supplies factor VII to support clot formation. - Protein C deficiency: delivers protein C to reduce risk of thrombosis. - Protein S deficiency: provides protein S to aid anticoagulant pathways. - Acquired coagulopathy in liver disease: supplements multiple factors to improve hemostasis.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Adverse reactions may occur following administration of Octaplex.

Common Side Effects: - Fever - Chills - Infusion‑site erythema - Headache - Nausea - Mild hypotension

Serious or Rare Side Effects: - Anaphylactic reaction - Thromboembolic events - Development of inhibitory antibodies - Hemolysis - Severe hypertension - Disseminated intravascular coagulation

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex should be used with careful clinical monitoring. - Dose adjustment: individualize based on factor levels and patient response. - Screening: test for inhibitors before initiating therapy. - Concomitant anticoagulants: monitor coagulation parameters closely. - Pregnancy and lactation: weigh benefits against potential risks. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex may interact with other agents affecting hemostasis.

Major Interactions (Avoid): - Antifibrinolytics: may increase risk of thrombosis. - Warfarin: overlapping anticoagulant effect can cause bleeding. - Heparin: additive anticoagulation may lead to hemorrhage.

Moderate Interactions (Monitor Closely): - Beta‑lactam antibiotics: possible reduced efficacy of protein C/S. - Vaccines: monitor for altered immune response. - Other plasma‑derived products: risk of inhibitor development.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a plasma‑derived clotting factor concentrate used to replace deficient coagulation proteins in patients with hemophilia B, congenital factor VII deficiency, protein C or protein S deficiency, and certain acquired coagulopathies. It helps control bleeding and prevents future hemorrhagic episodes when administered under medical supervision.
How does Human Coagulation Factor IX work in Octaplex?+
Human Coagulation Factor IX in Octaplex restores the intrinsic pathway of the clotting cascade by providing the missing factor IX protein. This enables activation of factor X, leading to thrombin generation and fibrin clot formation, thereby correcting the bleeding tendency associated with factor IX deficiency.
What is the usual dose of Octaplex?+
The dose of Octaplex is individualized by the prescribing clinician based on the patient’s specific factor deficiency, severity of bleeding, body weight, and laboratory factor activity levels. Only a qualified healthcare professional should determine the appropriate dosing regimen.
Is Octaplex safe during pregnancy or breastfeeding?+
Octaplex may be used during pregnancy or lactation only when the expected benefit to the mother outweighs potential risks to the fetus or infant. Clinicians should evaluate each case carefully and discuss possible effects with the patient before initiating therapy.
How do I order Octaplex from GNH USA?+
To request Octaplex, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and necessary import documentation.
How does Octaplex compare with other clotting factor products?+
Octaplex is a multi‑component plasma‑derived concentrate containing factor IX, factor VII, protein C, protein S, and factor X, offering broader coverage than single‑factor products. This can be advantageous for patients with multiple deficiencies, whereas recombinant single‑factor concentrates target only one specific protein.
What are the storage and handling requirements for Octaplex?+
Octaplex must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before use, allow the vial to reach room temperature if required, and inspect for particulate matter or discoloration; discard if any abnormalities are observed.
How is Octaplex administered?+
Octaplex is supplied as a sterile injectable solution and is administered intravenously by a qualified healthcare professional. The infusion rate and volume are determined by the prescriber, and patients are monitored for any immediate adverse reactions during and after the infusion.
What are the most serious risks associated with Octaplex?+
Serious risks include anaphylactic reactions, development of inhibitory antibodies against clotting factors, thromboembolic events, severe hypertension, hemolysis, and disseminated intravascular coagulation. Prompt recognition and medical intervention are essential if any of these events occur.
Who should not use Octaplex?+
Octaplex is contraindicated in patients with known hypersensitivity to any of its protein components or to the excipients used in the formulation. It should also be avoided in individuals with a history of severe allergic reactions to plasma‑derived products unless the benefits clearly outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU